Correlation Between Simris Alg and Hansa Biopharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between Simris Alg AB and Hansa Biopharma AB, you can compare the effects of market volatilities on Simris Alg and Hansa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Simris Alg with a short position of Hansa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Simris Alg and Hansa Biopharma.
Diversification Opportunities for Simris Alg and Hansa Biopharma
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Simris and Hansa is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Simris Alg AB and Hansa Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansa Biopharma AB and Simris Alg is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Simris Alg AB are associated (or correlated) with Hansa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansa Biopharma AB has no effect on the direction of Simris Alg i.e., Simris Alg and Hansa Biopharma go up and down completely randomly.
Pair Corralation between Simris Alg and Hansa Biopharma
Assuming the 90 days trading horizon Simris Alg AB is expected to under-perform the Hansa Biopharma. In addition to that, Simris Alg is 1.45 times more volatile than Hansa Biopharma AB. It trades about -0.01 of its total potential returns per unit of risk. Hansa Biopharma AB is currently generating about 0.0 per unit of volatility. If you would invest 5,900 in Hansa Biopharma AB on September 3, 2024 and sell it today you would lose (2,650) from holding Hansa Biopharma AB or give up 44.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Simris Alg AB vs. Hansa Biopharma AB
Performance |
| Timeline |
| Simris Alg AB |
| Hansa Biopharma AB |
Simris Alg and Hansa Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Simris Alg and Hansa Biopharma
The main advantage of trading using opposite Simris Alg and Hansa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Simris Alg position performs unexpectedly, Hansa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansa Biopharma will offset losses from the drop in Hansa Biopharma's long position.| Simris Alg vs. SenzaGen AB | Simris Alg vs. AAK AB | Simris Alg vs. Scibase AB | Simris Alg vs. Scandinavian Enviro Systems |
| Hansa Biopharma vs. Simris Alg AB | Hansa Biopharma vs. Immunovia publ AB | Hansa Biopharma vs. Sedana Medical AB | Hansa Biopharma vs. KABE Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |